These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32732624)

  • 41. A prospective randomized controlled trial comparing target prostate biopsy alone approach vs. target plus standard in naïve patients with positive mpMRI.
    Porpiglia F; Checcucci E; DE Cillis S; Piramide F; Amparore D; Piana A; Volpi G; Granato S; Zamengo D; Stura I; Alladio E; Migliaretti G; DE Luca S; Bollito E; Gned D; DI Dio M; Autorino R; Manfredi M; Fiori C
    Minerva Urol Nephrol; 2023 Feb; 75(1):31-41. PubMed ID: 36626117
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeted vs systematic robot-assisted transperineal magnetic resonance imaging-transrectal ultrasonography fusion prostate biopsy.
    Mischinger J; Kaufmann S; Russo GI; Harland N; Rausch S; Amend B; Scharpf M; Loewe L; Todenhoefer T; Notohamiprodjo M; Nikolaou K; Stenzl A; Bedke J; Kruck S
    BJU Int; 2018 May; 121(5):791-798. PubMed ID: 29211932
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dynamic evaluation of MRI-targeted, systematic and combined biopsy for prostate cancer diagnosis through 10 years of practice in a single institution.
    Lenfant L; Renard-Penna R; de Rycke Y; Rouprêt M; Beaugerie A; Comperat E; Chartier-Kastler E; Mozer PC
    World J Urol; 2022 Jul; 40(7):1661-1668. PubMed ID: 35482073
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Should we perform systematic biopsies in case of suspicious MRI for prostate cancer in 2020? A review of literature.
    Vesval Q; Fiard G; Villers A; Norris JM; Olivier J
    Prog Urol; 2021 Mar; 31(3):147-157. PubMed ID: 33189555
    [TBL] [Abstract][Full Text] [Related]  

  • 45. There Is No Way to Avoid Systematic Prostate Biopsies in Addition to Multiparametric Magnetic Resonance Imaging Targeted Biopsies.
    Dell'Oglio P; Stabile A; Soligo M; Brembilla G; Esposito A; Gandaglia G; Fossati N; Bravi CA; Dehò F; De Cobelli F; Montorsi F; Karnes RJ; Briganti A
    Eur Urol Oncol; 2020 Feb; 3(1):112-118. PubMed ID: 31411973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Positive pre-biopsy MRI: are systematic biopsies still useful in addition to targeted biopsies?
    Ploussard G; Borgmann H; Briganti A; de Visschere P; Fütterer JJ; Gandaglia G; Heidegger I; Kretschmer A; Mathieu R; Ost P; Sooriakumaran P; Surcel C; Tilki D; Tsaur I; Valerio M; van den Bergh R;
    World J Urol; 2019 Feb; 37(2):243-251. PubMed ID: 29967944
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prostate Cancer Risk Assessment in Biopsy-naïve Patients: The Rotterdam Prostate Cancer Risk Calculator in Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound (TRUS) Fusion Biopsy and Systematic TRUS Biopsy.
    Mannaerts CK; Gayet M; Verbeek JF; Engelbrecht MRW; Savci-Heijink CD; Jager GJ; Gielens MPM; van der Linden H; Beerlage HP; de Reijke TM; Wijkstra H; Roobol MJ
    Eur Urol Oncol; 2018 Jun; 1(2):109-117. PubMed ID: 31100233
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Role of Ipsilateral and Contralateral Transrectal Ultrasound-guided Systematic Prostate Biopsy in Men With Unilateral Magnetic Resonance Imaging Lesion Undergoing Magnetic Resonance Imaging-ultrasound Fusion-targeted Prostate Biopsy.
    Bryk DJ; Llukani E; Taneja SS; Rosenkrantz AB; Huang WC; Lepor H
    Urology; 2017 Apr; 102():178-182. PubMed ID: 27871829
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of Cancer Detection Rates Between TRUS-Guided Biopsy and MRI-Targeted Biopsy According to PSA Level in Biopsy-Naive Patients: A Propensity Score Matching Analysis.
    Choi YH; Kang MY; Sung HH; Jeon HG; Chang Jeong B; Seo SI; Jeon SS; Kim CK; Park BK; Lee HM
    Clin Genitourin Cancer; 2019 Feb; 17(1):e19-e25. PubMed ID: 30415878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Additional value of magnetic resonance-targeted biopsies to standard transrectal ultrasound-guided biopsies for detection of clinically significant prostate cancer.
    von Below C; Wassberg C; Norberg M; Tolf A; Kullberg J; Ladjevardi S; Häggman M; Bill Axelson A; Ahlström H
    Scand J Urol; 2017 Apr; 51(2):107-113. PubMed ID: 28635568
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer.
    Stabile A; Dell'Oglio P; De Cobelli F; Esposito A; Gandaglia G; Fossati N; Brembilla G; Cristel G; Cardone G; Deho' F; Losa A; Suardi N; Gaboardi F; Del Maschio A; Montorsi F; Briganti A
    Eur Urol Oncol; 2018 May; 1(1):29-36. PubMed ID: 31100225
    [TBL] [Abstract][Full Text] [Related]  

  • 52. What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.
    Moldovan PC; Van den Broeck T; Sylvester R; Marconi L; Bellmunt J; van den Bergh RCN; Bolla M; Briers E; Cumberbatch MG; Fossati N; Gross T; Henry AM; Joniau S; van der Kwast TH; Matveev VB; van der Poel HG; De Santis M; Schoots IG; Wiegel T; Yuan CY; Cornford P; Mottet N; Lam TB; Rouvière O
    Eur Urol; 2017 Aug; 72(2):250-266. PubMed ID: 28336078
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of Multiparametric MRI-targeted and Systematic Biopsies for Detection of Cribriform and Intraductal Carcinoma Prostate Cancer.
    Ghai S; Klotz L; Pond GR; Kebabdjian M; Downes MR; Belanger EC; Moussa M; van der Kwast TH
    Radiology; 2024 Jul; 312(1):e231948. PubMed ID: 39012252
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of clinically significant prostate cancer in biopsy-naïve men: direct comparison of systematic biopsy, multiparametric MRI- and contrast-ultrasound-dispersion imaging-targeted biopsy.
    Mannaerts CK; Engelbrecht MRW; Postema AW; van Kollenburg RAA; Hoeks CMA; Savci-Heijink CD; Van Sloun RJG; Wildeboer RR; De Reijke TM; Mischi M; Wijkstra H
    BJU Int; 2020 Oct; 126(4):481-493. PubMed ID: 32315112
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prostate cancer: diagnostic yield of modified transrectal ultrasound-guided twelve-core combined biopsy (targeted plus systematic biopsies) using prebiopsy magnetic resonance imaging.
    Song C; Park SY
    Abdom Radiol (NY); 2021 Oct; 46(10):4974-4983. PubMed ID: 34181040
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elastic Versus Rigid Image Registration in Magnetic Resonance Imaging-transrectal Ultrasound Fusion Prostate Biopsy: A Systematic Review and Meta-analysis.
    Venderink W; de Rooij M; Sedelaar JPM; Huisman HJ; Fütterer JJ
    Eur Urol Focus; 2018 Mar; 4(2):219-227. PubMed ID: 28753777
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systematic prostate biopsy still matters: A comprehensive analysis of MRI/TRUS-fusion targeted prostate biopsies across different indications.
    Westhoff N; Baeßler B; von Hardenberg J; Hetjens S; Porubsky S; Siegel F; Martini T; Michel MS; Attenberger U; Ritter M
    Urol Oncol; 2019 Oct; 37(10):678-687. PubMed ID: 31375340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Magnetic resonance imaging-transrectal ultrasound fusion image-guided prostate biopsy: Current status of the cancer detection and the prospects of tailor-made medicine of the prostate cancer.
    Shoji S
    Investig Clin Urol; 2019 Jan; 60(1):4-13. PubMed ID: 30637355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlation of 3T multiparametric prostate MRI using prostate imaging reporting and data system (PIRADS) version 2 with biopsy as reference standard.
    Mathur S; O'Malley ME; Ghai S; Jhaveri K; Sreeharsha B; Margolis M; Zhong L; Maan H; Toi A
    Abdom Radiol (NY); 2019 Jan; 44(1):252-258. PubMed ID: 30032385
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transperineal magnetic resonance imaging targeted biopsy versus transrectal route in the detection of prostate cancer: a systematic review and meta-analysis.
    Wu Q; Tu X; Zhang C; Ye J; Lin T; Liu Z; Yang L; Qiu S; Bao Y; Wei Q
    Prostate Cancer Prostatic Dis; 2024 Jun; 27(2):212-221. PubMed ID: 37783837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.